THARIMMUNE INC (THAR) Stock News

USA - NASDAQ:THAR - US4327053090 - Common Stock

3.09 USD

+0.19 (+6.55%)

Last: 10/24/2025, 8:00:01 PM

3.09 USD

0 (0%)

After Hours: 10/24/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

THAR Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Benzinga - Mentions: CCCC MBX HSDT ADVM ...

12 Health Care Stocks Moving In Monday's Intraday Session

a month ago - By: Benzinga - Mentions: GRI BRTX ONCO MBX ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

2 months ago - By: Yahoo Finance

Tharimmune (THUR) Tumbles 20.7% on $5-Million Share Sale

2 months ago - By: ACCESS Newswire

Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments

2 months ago - By: ACCESS Newswire

Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl

3 months ago - By: ACCESS Newswire

Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors

3 months ago - By: ACCESS Newswire

Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral Antibody Delivery